Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Brexucabtagene autoleucel ca (EAPG C9073) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 29, 2026 , from http://ppman.hank.ai/transparency/procedure/C9073/by-state?code_type=EAPG
“Brexucabtagene autoleucel ca (EAPG C9073) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/C9073/by-state?code_type=EAPG. Accessed
June 29, 2026 .
“Brexucabtagene autoleucel ca (EAPG C9073) by State,” HANK Price Transparency ,
accessed June 29, 2026 ,
http://ppman.hank.ai/transparency/procedure/C9073/by-state?code_type=EAPG.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
EAPG · across United States
C9073 — Brexucabtagene Autoleucel Ca
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$25,396
National median
$25,396 – $62,026
IQR (p25 – p75)
5
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for C9073 (EAPG), with interquartile range
State Median p25 p75
AL $72,542 $72,542 $72,542
FL $25,396 $25,396 $25,396